Mymetics Corporation Receivables Turnover Ratio (MYMX), from the third quarter 2023 to the third quarter 2022 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Mymetics Corporation  (MYMX)
 

Mymetics Accounts Receivables Turnover Ratio from the third quarter 2023 to the third quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Mymetics Corporation's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2023 to a ratio of 11.39, above the company average. This is a clear sign of healthy business climate in the Biotechnology & Pharmaceuticals industry and improving liquidity at their respective customers, during the third quarter 2023. Average receivable collection period, for the Mymetics in Sep 30 2023 quarter, has decreased to 32 days, compared to 34 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 409 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2023 from 604 to 2745.

What is Receivable Turnover Ratio?
What is Mymetics Corporation Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MYMX Receivables Turnover Ratio (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Receivable Change -77.59 % -22.22 % -76.56 % 362.93 % 81.25 %
Y / Y Revenue Change -73.85 % -37.71 % -42.98 % 54.99 % 58.54 %
Receivable Turnover Ratio (TTM) 11.39 10.87 12.09 7.35 7.84
MYMX's Total Ranking # 2745 # 604 # 604 # 0 # 0
Accounts Receivable average collection period days 32 34 30 50 47
Seq. Receivable Change -69.05 % -51.16 % 38.71 % 6.9 % 7.41 %
Seq. Revenue Change -81.62 % -33.21 % 238.57 % -37.07 % -56.23 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 29
Healthcare Sector # 410
Overall Market # 2745

Receivable Turnover Ratio Statistics
High Average Low
0.29 0.15 -0.03
(Sep 30 2023)   (June 30. 2016)





MYMX Company Profile • Back to MYMX Efficiency Comparisons • Compare MYMX Receivables Turnover Ratio to its Competitors

Financial Statements
Mymetics's Accounts Receivable $ 0 Millions Visit MYMX's Balance sheet
Mymetics's Sales TTM $ 1 Millions Visit MYMX's Income Statement
Sources of MYMX's Revenues Visit MYMX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MYMX's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
MYMX's Growth Rates MYMX's Roa MYMX's Inventory Turnover Ratio MYMX's Dividend Comparisons
MYMX's Profitability Ratios MYMX's Roi MYMX's Asset Turnover Ratio MYMX's Dividend Growth
MYMX's Valuation Ratios MYMX's Roe MYMX's Financial Strength Ratios MYMX's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Receivable at quarter ending Sep 30 2023
Healthlynked Corp  118.06 $ 5.946  Millions$ 0.050  Millions
Relay Therapeutics Inc   117.14 $ 25.800  Millions$ 0.220  Millions
Iterum Therapeutics Plc  115.26 $ 14.321  Millions$ 0.124  Millions
Electromedical Technologies Inc   113.10 $ 1.420  Millions$ 0.013  Millions
Prothena Corporation Public Limited Company  99.23 $ 140.977  Millions$ 1.421  Millions
Orthofix Medical Inc   98.14 $ 667.747  Millions$ 6.804  Millions
Logicmark Inc  80.11 $ 9.650  Millions$ 0.120  Millions
Alpine Immune Sciences Inc   78.82 $ 30.799  Millions$ 0.391  Millions
Renalytix Plc  77.82 $ 5.778  Millions$ 0.074  Millions
Tango Therapeutics Inc   75.01 $ 37.507  Millions$ 0.500  Millions
Kymera Therapeutics Inc   74.95 $ 46.846  Millions$ 0.625  Millions
Longduoduo Co Ltd  69.41 $ 4.990  Millions$ 0.072  Millions
Lifevantage Corp  67.38 $ 212.421  Millions$ 3.153  Millions
Pavmed Inc   63.57 $ 1.923  Millions$ 0.030  Millions
Scynexis Inc   62.10 $ 135.869  Millions$ 2.188  Millions
Clearday Inc   61.82 $ 7.543  Millions$ 0.122  Millions
Agenus Inc  61.81 $ 100.897  Millions$ 1.632  Millions
Zeo Scientifix Inc   61.17 $ 4.558  Millions$ 0.075  Millions
Lucid Diagnostics Inc   60.00 $ 1.500  Millions$ 0.025  Millions
Airsculpt Technologies Inc   59.60 $ 189.013  Millions$ 3.171  Millions
Brookdale Senior Living Inc   57.81 $ 2,949.838  Millions$ 51.031  Millions
Marpai Inc  50.33 $ 36.077  Millions$ 0.717  Millions
Wave Life Sciences Ltd   48.85 $ 85.488  Millions$ 1.750  Millions
Rosecliff Acquisition Corp I  45.35 $ 16.315  Millions$ 0.360  Millions
Janux Therapeutics Inc   45.16 $ 8.467  Millions$ 0.188  Millions
Sangamo Therapeutics Inc   44.25 $ 201.420  Millions$ 4.552  Millions
Aclaris Therapeutics Inc   44.03 $ 21.432  Millions$ 0.487  Millions
Aridis Pharmaceuticals Inc   41.46 $ 22.359  Millions$ 0.539  Millions
Vivos Therapeutics Inc   41.42 $ 13.803  Millions$ 0.333  Millions
Lite Strategy Inc   40.65 $ 105.383  Millions$ 2.592  Millions

Date modified: 2026-09-08T15:11:07+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.